Infectious diseases in systemic lupus erythematosus: risk factors, management and prophylaxis.
about
Mice chronically fed high-fat diet have increased mortality and disturbed immune response in sepsisLymphopenia at presentation is associated with increased risk of infections in patients with systemic lupus erythematosusSerious infections in patients with rheumatoid arthritis and other immune-mediated connective tissue diseases exposed to anti-TNF or rituximab: data from the Spanish registry BIOBADASER 2.0.Sometimes There Is More Than One Puzzle on the Table: Pneumococcal Bacteremia as a New Systemic Lupus Erythematosus Presentation.Rates of serious intracellular infections in autoimmune disease patients receiving initial glucocorticoid therapy.Treatment of active lupus nephritis with the novel immunosuppressant 15-deoxyspergualin: an open-label dose escalation study.Influenza vaccination responses in human systemic lupus erythematosus: impact of clinical and demographic featuresHigh Affinity Antibodies against Influenza Characterize the Plasmablast Response in SLE Patients After Vaccination.Vaccinations in paediatric rheumatology: an update on current developments.Immunization in Patients with Rheumatic Diseases: A Practical Guide for General Practitioners.Amyloid-DNA Composites of Bacterial Biofilms Stimulate AutoimmunityImmunogenicity and Safety of Influenza Vaccination in Systemic Lupus Erythematosus Patients Compared with Healthy Controls: A Meta-Analysis.Environment and systemic lupus erythematosus: an overview.Infections and SLE.Rituximab-treated patients have a poor response to influenza vaccinationEffects of annual influenza vaccination on morbidity and mortality in patients with Systemic Lupus Erythematosus: A Nationwide Cohort Study.Prognostic factors in patients with systemic lupus erythematosus admitted to the intensive care unit.Lethal manifestations of systemic lupus erythematosus in a forensic context.Comparison of national clinical practice guidelines and recommendations on vaccination of adult patients with autoimmune rheumatic diseases.Safety issues and concerns of new immunomodulators in rheumatology.Mycobacteria and autoimmunity.Infection-related hospitalization and risk of end-stage renal disease in patients with systemic lupus erythematosus: a nationwide population-based study.Protective effect of A/H1N1 vaccination in immune-mediated disease--a prospectively controlled vaccination study.The risk of tuberculosis in SLE patients from an Asian tertiary hospital.Systemic lupus erythematosus and infections: a retrospective study in Saudis.Fatal sepsis by Klebsiella pneumoniae in a patient with systemic lupus erythematosus: the importance of postmortem microbiological examination for the ex post diagnosis of infection.Cryptococcosis in systemic lupus erythematosus: a series of six cases.Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: an open, prospective, controlled study.Serious infections in British patients with systemic lupus erythematosus: hospitalisations and mortality.Death-related factors of systemic lupus erythematosus patients associated with the course of disease in Chinese populations: multicenter and retrospective study of 1,958 inpatients.High risk of tuberculosis in systemic lupus erythematosus?Invasive fungal infections in patients with systemic lupus erythematosus: experience from affiliated hospitals of Catholic University of Korea.The safety of live-attenuated vaccines in patients using IL-1 or IL-6 blockade: an international survey.
P2860
Q27336723-69250963-EE79-43E4-8D95-AFEB602E160DQ28288186-3FE455DC-D351-4469-AD91-FFFF51D88B67Q30731527-D0E64193-9B5A-4983-89A6-996576153984Q33362367-7097FA83-B57E-4DBD-AA9E-D657A6E30272Q35048101-4BCDF38E-E299-49C4-84D1-58F1CDC03CFAQ35092872-987F7B85-1B2B-414E-B05B-E949F29E0402Q35146181-86A2272F-274F-454E-82E7-F1DA047ACFDFQ35624357-57CD7F90-3419-4792-92B1-2BB65A94CA3FQ35666223-E150381A-14AD-4F4C-BB5C-993CFD605A8CQ35792458-62C044C7-4B4F-4CE3-8B62-9AB3813FB687Q35845485-D4DD8AD1-FCA5-425F-B996-30BC3F3FF59AQ35914564-0D58CDA9-803A-48BF-8BCC-878AF25DA435Q36350796-FDAD47EC-5C6C-442F-9AB5-9A8C09C748FFQ36350798-D20B1989-E391-45DC-A937-007F0F854107Q36589247-57679A1F-E148-409C-90CF-984B3432F265Q37464655-E709300F-C1E3-45FE-8C61-7FC1F0BFB2D6Q37619974-791742E3-8B19-4C28-88EB-8B7C5D69EBE8Q37838467-62993F9A-2CF3-4AC7-8EE0-4E43AAC97046Q38169909-C568E129-ABA8-4E7B-8EAF-9AAA4712A79FQ38292111-A1785BED-F05B-4093-AE34-448A41A0CB3DQ38388403-5FE6E047-D6C2-448F-9BDE-32D317D86880Q39067699-CD30A75A-5104-4CA1-B1DD-1FA005C500B1Q39675557-AC9224C3-1108-4400-B8A4-42848433229BQ40295442-C961FEED-E807-4672-90B1-A263F359361CQ40440734-62674417-22F6-4644-8F8F-B7931E06437DQ41486437-EF4E8E7F-F4B7-4F49-844A-1CCCE6199B4CQ43179445-9B046AA8-0213-4DE6-A52A-C7019F759078Q44197482-62A309A9-6199-4531-A221-3BD5CE01C484Q45349765-23B25281-8A64-4D1F-9EC0-026D77E768E5Q48243057-99D7B97E-2E4D-4424-BA3F-C436441EA6BDQ50781873-A8D25372-6C33-4425-AD4C-60A39CCCB2A4Q51830827-A58D1C66-5D5B-4F10-9507-A6E144B853E9Q54251597-D3E8753A-8B4C-4487-9FA0-4ED2E86A0833
P2860
Infectious diseases in systemic lupus erythematosus: risk factors, management and prophylaxis.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Infectious diseases in systemi ...... s, management and prophylaxis.
@ast
Infectious diseases in systemi ...... s, management and prophylaxis.
@en
Infectious diseases in systemi ...... s, management and prophylaxis.
@nl
type
label
Infectious diseases in systemi ...... s, management and prophylaxis.
@ast
Infectious diseases in systemi ...... s, management and prophylaxis.
@en
Infectious diseases in systemi ...... s, management and prophylaxis.
@nl
prefLabel
Infectious diseases in systemi ...... s, management and prophylaxis.
@ast
Infectious diseases in systemi ...... s, management and prophylaxis.
@en
Infectious diseases in systemi ...... s, management and prophylaxis.
@nl
P356
P1476
Infectious diseases in systemi ...... s, management and prophylaxis.
@en
P2093
Barri J Fessler
P304
P356
10.1053/BERH.2001.0226
P577
2002-04-01T00:00:00Z